tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher Raymond, 390 are a BUY (81.93%), 80 are a HOLD (16.81%), 6 are a SELL (1.26%).
Analyst Christopher Raymond, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 50.45% that have a potential upside of 39.63% achieved within 282 days.
Christopher Raymond’s has documented 939 price targets and ratings displayed on 54 stocks. The coverage is on Healthcare, Consumer Cyclical, Energy, Basic Materials, Technology sectors.
Most recent stock forecast was given on ARDX, Ardelyx at 17-Aug-2026.
Analyst best performing recommendations are on ALXO (ALX ONCOLOGY HOLDINGS ).
The best stock recommendation documented was for ALXO (ALX ONCOLOGY HOLDINGS ) at 11/18/2020. The price target of $70 was fulfilled within 1 day with a profit of $5.5 (8.53%) receiving and performance score of 85.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$60 (23.53%)
$265
Buy Since 12-Sep-2025
$303
$48 (18.82%)
$298
22 days ago
(20-Aug-2026)
2/8 (25%)
$41.17 (15.72%)
35
Buy Since 07-Dec-2021
$300
$45 (17.65%)
$295
25 days ago
(17-Aug-2026)
9/11 (81.82%)
$49.67 (19.84%)
469
Buy Since 22-Jan-2023
$260
$5 (1.96%)
$235
1 months 1 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
127
Buy Since 05-Feb-2020
$288
$33 (12.94%)
$261
1 months 7 days ago
(04-Aug-2026)
36/37 (97.3%)
$44.2 (18.13%)
434
Which stock is Christopher Raymond most bullish on?
Which stock is Christopher Raymond most reserved on?
What Year was the first public recommendation made by Christopher Raymond?
